Lunai Bioworks, Inc. (NASDAQ: LNAI), an AI-driven drug discovery and biodefense company, today announced that its subsidiary, BioSymetrics, has entered into a revenue-generating, commercial ...

Advancing AI-enabled chemical threat detection and dual-use biodefense technologies through initial commercial deployment SACRAMENTO, Calif., April 7, 2026 /PRNewswire/ -- Lunai Bioworks, ...

Dhruv Patel's work demonstrates how advanced expertise in distributed systems, AI, and cybersecurity can influence digital ...

Kyle Suess is co-founder of Amira Labs. During the NAB Show he will give a talk about “Myriad Uses of AI in Media,” including ...